Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Cardiac Failure|March 18, 2021
The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF TrialBrystana G Kaufman, Bradi B Granger, Jie-Lena Sun, et al.
JAMA Network Open|July 9, 2026
P2Y12 Inhibitors and Mortality in Patients Hospitalized With Intracerebral HemorrhageChen Jin, Ying Song, Brian Mac Grory, et al.
Journal of the American Heart Association|May 9, 2023
Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection FractionJosephine Harrington, Jie-Lena Sun, Gregg C Fonarow, et al.
Stroke|August 1, 2013
Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trialDavid Preiss, Thomas D Giles, Laine E Thomas, et al.
Circulation. Heart Failure|November 19, 2015
Psychosocial Factors, Exercise Adherence, and Outcomes in Heart Failure Patients: Insights From Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)Lauren B Cooper, Robert J Mentz, Jie-Lena Sun, et al.
Journal of Diabetes and Its Complications|March 21, 2017
Updated risk factors should be used to predict development of diabetesMary Angelyn Bethel, Kristen A Hyland, Antonio R Chacra, et al.
Metabolism: Clinical and Experimental|February 25, 2014
Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATORKim M Huffman, Jie-Lena Sun, Laine Thomas, et al.
Journal of Thrombosis and Thrombolysis|June 14, 2017
Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndromeAngela Lowenstern, Robert F Storey, Megan Neely, et al.
American Heart Journal|May 22, 2012
Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery diseaseSvati H Shah, Jie-Lena Sun, Robert D Stevens, et al.
BMJ Open|December 4, 2012
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trialDavid Preiss, Laine E Thomas, Jie-Lena Sun, et al.
Pageof 9